Phenomenex CEO Elected to American Red Cross L.A. Region Board of Directors
Fasha (Farshad) Mahjoor, CEO of Phenomenex (California, USA), has been elected to the American Red Cross Los Angeles Region Board of Directors. The appointment follows the award of the Ellis Island Medal of Honor to Mahjoor earlier this year, for building a socially responsible international business and for his humanitarian efforts in the USA and worldwide.
Fasha (Farshad) Mahjoor, CEO of Phenomenex (California, USA), has been elected to the American Red Cross Los Angeles Region Board of Directors. The appointment follows the award of the Ellis Island Medal of Honor to Mahjoor earlier this year, for building a socially responsible international business and for his humanitarian efforts in the USA and worldwide.
The L.A. volunteer-led region is the second largest in the USA, serving 88 cities, and providing relief for victims of natural or man-made disasters. In 2012 alone, nearly 160,000 people were trained in life-saving skills, including CPR and first aid, as a result of the Red Cross’s work.
Mahjoor said: “I am honoured to be invited to be an American Red Cross Board Member. It is a privilege, and I will carry on the duties to the best of my ability. I hope I can be a valuable member and that my contributions will make a real difference.”
“We welcome Mr Mahjoor to this board of talented and respected business leaders who are committed to helping others,” said Board Chair Martin Cozyn, Executive Vice President, Human Resources at Occidental Petroleum. “Working with five local chapter boards - in Long Beach, Santa Monica, Pasadena, Glendale, and Antelope Valley - we ensure the Red Cross is there to assist families and individuals across the region.”
For more information please visit:
www.RedCrossLA.org
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
